Horizon Therapeutics (BSP:H1ZN34) Total Equity : R$25,778 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Horizon Therapeutics Total Equity?

Horizon Therapeutics's total equity for the quarter that ended in Jun. 2023 was R$25,778 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Horizon Therapeutics Total Equity Historical Data

The historical data trend for Horizon Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Horizon Therapeutics Total Equity Chart

Horizon Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Equity

Get a 7-Day Free Trial

4,621.66

8,970.18

20,709.22

26,421.92

26,605.58

Horizon Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Equity	Get a 7-Day Free Trial															24,963.56	26,394.64	26,605.58	26,540.73	25,777.80

Horizon Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Horizon Therapeutics's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2022 )	-	Total Liabilities(Q: Dec. 2022 )
	=	47809.807	-	21204.225
	=	26,606

Horizon Therapeutics's Total Equity for the quarter that ended in Jun. 2023 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2023 )	-	Total Liabilities(Q: Jun. 2023 )
	=	45133.299	-	19355.497
	=	25,778

Horizon Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of Horizon Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Horizon Therapeutics (BSP:H1ZN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Horizon Therapeutics PLC (BSP:H1ZN34) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

70 St. Stephen’s Green, Dublin, IRL, D02 E2X4

Website

https://www.horizontherapeutics.com

Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Horizon Therapeutics (BSP:H1ZN34) Headlines

No Headlines